GovWhitePapers Logo

Sorry, your browser is not compatible with this application. Please use the latest version of Google Chrome, Mozilla Firefox, Microsoft Edge or Safari.

China and Medical AI: Implications of Big Biodata for the Bioeconomy

Medical artificial intelligence, which depends on large repositories of biological data, can improve public health and contribute to the growing global bioeconomy. Countries that strategically prioritize medical AI could benefit from a competitive advantage and set global norms.

This report examines China’s stated goals for medical AI, finding that the country’s strategy for biodata collection and medical AI development positions it to be an economic and technological leader in this sector.

  • Author(s):
  • Caroline Schuerger
  • Vikram Venkatram
  • Katherine Quinn
  • Share this:
  • Share on Facebook
  • Share on Twitter
  • Share via Email
  • Share on LinkedIn
China and Medical AI: Implications of Big Biodata for the Bioeconomy
  • White Paper
Website:Visit Publisher Website
Publisher:Center for Security and Emerging Technology
Published:May 1, 2024
License:Creative Commons
Copyright:© 2024 by the Center for Security and Emerging Technology. This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. To view a copy of this license, visit

Featured Content

Contact Publisher

Claim Content